Matches in Nanopublications for { ?s ?p "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP789396.RAtRwLrJup70TnPIzq1nVI8dZJS5KopRPo3QtScy9aYC4130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789396.RAtRwLrJup70TnPIzq1nVI8dZJS5KopRPo3QtScy9aYC4130_provenance.
- NP499466.RAdpnE6NdV8GyZhWVuqFMmzZEd1FNc_0zmV9TtsE67OFc130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499466.RAdpnE6NdV8GyZhWVuqFMmzZEd1FNc_0zmV9TtsE67OFc130_provenance.
- NP461748.RAZ7kHCAnCIlLBCRTJLYWxdJEQ-vImDd2JptqiPePTX4k130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461748.RAZ7kHCAnCIlLBCRTJLYWxdJEQ-vImDd2JptqiPePTX4k130_provenance.
- assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP914277.RAmsUmfKeRPn5N7lI5sU68MmwiNjiY0W6wMfezmHqIXRI130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914277.RAmsUmfKeRPn5N7lI5sU68MmwiNjiY0W6wMfezmHqIXRI130_provenance.
- NP521824.RA3pfHcsWNgmOmpBtlG27KRucvlSGu9uEhS2xnGtotHxY130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521824.RA3pfHcsWNgmOmpBtlG27KRucvlSGu9uEhS2xnGtotHxY130_provenance.
- NP770357.RAHlWcf_wwKxhpmntYHXOvluuGIfay76n4k7Zhn8EuAfk130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770357.RAHlWcf_wwKxhpmntYHXOvluuGIfay76n4k7Zhn8EuAfk130_provenance.
- NP380701.RAm07qjXW-qS4nIboP8_DAg7TcH-zad1c9MKBE8n46-zs130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380701.RAm07qjXW-qS4nIboP8_DAg7TcH-zad1c9MKBE8n46-zs130_provenance.
- NP671949.RAufnf6xMrXIhZ5tsRcUOrDuSY28ekhcG34C_kS5dT9So130_assertion description "[Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671949.RAufnf6xMrXIhZ5tsRcUOrDuSY28ekhcG34C_kS5dT9So130_provenance.